Primary prevention of atrial fibrillation in patients with metabolic syndrome: correction of modifiable risk factors
Currently, around 34 million people worldwide suffer from atrial fibrillation (AF), with the number projected to double by 2060. Despite the treatment of AF has been significantly improved during the recent years, AF is still associated with an increased risk of severe complications such as systemic...
Saved in:
| Main Authors: | A. I. Olesin, I. V. Konstantinova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Kemerovo State Medical University
2021-07-01
|
| Series: | Фундаментальная и клиническая медицина |
| Subjects: | |
| Online Access: | https://fcm.kemsmu.ru/jour/article/view/410 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A POSSIBILITY TO USE ANTIARRHYTHMIC MEDICATIONS FROM II CLASS AND MODULATED KINESITHERAPY AS PRIMARY PREVENTION OF ATRIAL FIBRILLATION IN METABOLIC SYNDROME PATIENTS
by: A. I. Olesin, et al.
Published: (2015-11-01) -
Comorbid Patients with Abdominal Obesity and High Risk of Atrial Fibrillation: Correction of Modifiable Risk Factors as a Strategy of Primary Prevention (Prospective Study)
by: A. I. Olesin, et al.
Published: (2024-03-01) -
ATRIAL FIBRILLATION ONSET RISK IN PATIENTS WITH METABOLIC SYNDROME: PROSPECTIVE STUDY
by: A. I. Olesin, et al.
Published: (2014-12-01) -
UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION
by: E. A. Protasova, et al.
Published: (2015-12-01) -
Statins in Secondary Prevention of Atrial Fibrillation
by: V. I. Podzolkov, et al.
Published: (2016-11-01)